Collateral for a security interest recorded Feb 7, 2025 (Hayfin Services LLP).
Term ends May 31, 2039 · High confidence
20-year base term ends Oct 28, 2036
Held by Revance Therapeutics, Inc.
Filed Sep 10, 2021 as application 17/472,525 · Granted Sep 15, 2026
Base term plus 945 days of patent term adjustment (USPTO delay)
Today
2016
2039
Clock starts
Oct 28, 2016
Oct 28, 2016
Term ends
May 31, 2039
May 31, 2039
Granted
Sep 15, 2026
Sep 15, 2026
base term
patent term adjustment
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
945
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 945 days past its 20-year base term on prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 28, 2016, when application PCT/US2016/059492, the earliest non-provisional in its chain, was filed (this one was filed Sep 10, 2021) | Oct 28, 2036 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +945 days, USPTO patent term adjustment record | May 31, 2039 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | May 31, 2039 | High confidence |
This family
| Application PCT/US2016/059492 | PCT application no patent term | no patent term |
| Application 15/771,635 | Abandoned not computed | not computed |
| US 12,734,226 | this patent May 2039 | May 2039 |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Mar 16, 2022 Reel 59281, frame 37 | Ruegg, Curtis L. | Revance Therapeutics, Inc. | Assignment of Assignor's Interest |
| Mar 17, 2022 Reel 59435, frame 362 | Waugh, Jacob | Essentia Biosystems, Inc. | Employee Proprietary Information and Inventions Agreement |
| Mar 17, 2022 Reel 59435, frame 371 | Essentia Biosystems, Inc. | Revance Therapeutics, Inc. | Change of Name |
| Mar 18, 2022 Reel 59437, frame 654 | Revance Therapeutics, Inc. | Athyrium Buffalo LP | Security Interest |
| Feb 7, 2025 Reel 70153, frame 630 | Athyrium Buffalo LP | Revance Therapeutics, Inc. | Release of Security Interest |
| Feb 7, 2025 Reel 70153, frame 663 | Revance Therapeutics, Inc.; Crown Laboratories, Inc. | Hayfin Services LLP, as Administrative Agent | Security Interest |
| Feb 7, 2025 Reel 70153, frame 736 | Revance Therapeutics, Inc.; Bellus Medical, LLC; Crown Laboratories, Inc. | Hayfin Services LLP, as Administrative Agent | Security Interest |
| Feb 17, 2025 Reel 70239, frame 739 | Revance Therapeutics, Inc. | Jpmorgan Chase Bank, N.a. | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
May 2039
Term ends May 31, 2039. Maintenance fees still fall due before then
Note
The 945 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
We have no citation count for this patent yet. That is not the same as never having been cited.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.